Cizzle Biotechnology Holdings Plc (LON: CIZ)

Market Cap	7.53M
Revenue (ttm)	n/a
Net Income (ttm)	-2.70M
Shares Out	396.39M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	91,310
Open	1.830
Previous Close	1.900
Day's Range	1.765 - 1.948
52-Week Range	1.420 - 3.380
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 25, 2025

About CIZ

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Employees: 4
• Stock Exchange: London Stock Exchange
• Ticker Symbol: CIZ